Literature DB >> 8150777

Bisphosphonates in breast cancer patients with skeletal metastases.

C L Shapiro1.   

Abstract

The utility of bisphosphonates is well established in the treatment of acute hypercalcemia of malignancy. Bisphosphonates may also decrease the complications and morbidity of skeletal metastases. This article emphasizes the use of bisphosphonates in breast cancer patients with skeletal metastases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150777

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  1 in total

1.  The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.

Authors:  H A Harvey; A Lipton
Journal:  Support Care Cancer       Date:  1996-05       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.